Sun Loo

11PUBLICATIONS
94CO-AUTHORS
Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 04, 2026
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.

|Jul 29, 2025
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML.

Rithin Nedumannil, Michael Ashby, James Rowland

|Jan 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Chong Chyn Chua, Sun Loo, Chun Yew Fong

|Sep 24, 2024
How I treat patients with AML using azacitidine and venetoclax.

Andrew H Wei, Sun Loo, Naval Daver

|Sep 24, 2024
Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Sun Loo, Nicola Potter, Adam Ivey

|Mar 01, 2024
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Ing Soo Tiong, Devendra K Hiwase, Emad Abro

Pageof 2

Frequent Collaborators

10 joint publications

Andrew H Wei

7 joint publications

Ing Soo Tiong

6 joint publications

Natasha S Anstee

4 joint publications

Jad Othman